FRANCISCO JAVIER
AMPUDIA BLASCO
PROF. PERMANENTE LABORAL PPL
University of California, San Diego
San Diego, Estados UnidosPublicacións en colaboración con investigadores/as de University of California, San Diego (2)
2021
-
Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2
Diabetes, Obesity and Metabolism, Vol. 23, Núm. 3, pp. 854-860
2019
-
International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors
Diabetes Care, Vol. 42, Núm. 6, pp. 1147-1154